InvestorsHub Logo
Followers 11
Posts 879
Boards Moderated 0
Alias Born 10/27/2003

Re: DewDiligence post# 3248

Monday, 05/17/2010 3:40:25 PM

Monday, May 17, 2010 3:40:25 PM

Post# of 3757
Quote:
Because IDX184 is dosed in this trial for only 14 days, the 28-day data do not give a true RVR rate that one could compare with the RVR rate seen in other HCV trials.

Thank you. Somehow I missed that detail when I looked at IDIX update on the dosing study.

For fun I was watching the ticker tape......at 15.27.34 this afternoon, a trade was executed at $4.00 for 199,900 shares. Was a slow day up until that point. :)